Meta Description: 
In this webinar we explore Next Generation Sequencing applications for analyzing circulating analytes contained within liquid biopsy samples.
webinar science biology biotechnology masterclass master class

Challenges in RNA Processing and Analysis from Liquid Biopsies

LIVE Q&A WEBINAR

August 18, 2022

Register Now

Challenges in RNA Processing and Analysis from Liquid Biopsies

45 minute live Q&A

10:30 AM (EDT)
Register

Featured Speakers

Speakers:
Dr. M. Abdalla, MSc, PhD. - Director of Sales & Marketing,
Senior Research Scientist
Dr. Patricia Barbalho, MSc, PhD. - Research Scientist
Dr. Alex Chauhan, MSc, PhD. - Research Scientist
Moderator:
Michelle Stopher - Key Account Manager

Key Questions We Will Answer

  1. What is the best method of sample preparation to maintain RNA integrity for liquid biopsy samples?
  2. What is the expected yield of RNA from various liquid biopsy samples?
  3. What is the best method of quantification for ultra-low RNA concentrations?
  4. How can I maximize RNA concentration for downstream applications, such as NGS?
  5. What is the difference between RNA-seq and small RNA-seq, and which one should I use with my liquid biopsy samples?

Abstract

Join our expert panel of scientists in this Live Q&A session to explore all of the complexities of processing and analyzing RNA from liquid biopsy samples. Liquid biopsy samples are increasingly becoming one of the most valuable, minimally-invasive sources of information as the basis of diagnosis and disease monitoring as well as disease prevention. Biospecimens such as plasma, serum and urine contain various biomarkers that provide key insights into changes within the genome, epigenome, transcriptome and proteome of a patient. In this webinar, we'll answer all of your RNA questions related to biological specimen handling, RNA purification, quantification and downstream applications, including qRT-PCR and Next Generation Sequencing.

Patricia Barbalho and Alex Chauhan

About the speakers

Dr. Patricia Barbalho, PhD, is the most recent addition to Norgen's ever growing Research & Development Team. With a PhD in medical genetics, she currently works as a Research Scientist overseeing the testing and validation of Norgen's product portfolio including nucleic acid purification kits, MDx assays as well as biospecimen collection devices for regulatory submission for in vitro diagnostics. Dr. Barbalho plays an instrumental role in achieving regulatory certifications from international bodies for Norgen's product line including CE marking, Health Canada and the FDA.

Dr. Alex Chauhan, PhD, is a Research Scientist on Norgen's Next Generation Sequencing Services Team. With a PhD in applied sciences and cancer biology, Dr. Chauhan has extensive expertise working with liquid biopsy samples of all types. He oversees all client NGS projects, and specifically works with Small RNA-Sequencing for challenging ultra-low input sample types, such as cerebral spinal fluid and plasma/serum. In addition to his contributions to the NGS team, Dr. Chauhan holds a valuable role in Research & Development for Norgen's line of cell-free RNAand cell-free DNA purification kits.

×

SARS-CoV-2, The Flu and You

The Importance of Multiplex Detection and the Fourth Wave

The COVID-19 pandemic has taught us the value of early detection and mass testing initiatives to prevent viral spread. As we strive to get back to "normal", what does the 2021/22 Flu Season hold for us? Public Health Agencies are calling for better testing methods that can detect and differentiate COVID-19 and Influenza. Join the Team at Norgen Biotek Corp. for our first MasterClass on October 7th, 10am EDT, where we will compare Influenza and COVID-19 and how they differ, better understand the similarities between them and discuss new and emerging methods for multiplex detection of both viruses. We will also look at the progression of COVID-19 detection assays and how it relates to how we are handling the fourth wave.

49 min (Q&A included)

Featured Speaker:

Jaclyn Ugulini, B.Sc.
Sales & Marketing Manager
×

Urine Exosomes

Top 6 Strategies in Sample Handling

Urine has been steadily gaining popularity as a powerful tool for biomarker discovery as it is easy to collect, non-invasive and available in large quantities. More recently, exosomes have also been identified in urine and its inherent genetic material has proved to reflect an abundant amount of information related to an individual's pathophysiology. Traditional methods of sample handling are simply not robust enough for the molecular analysis required within precision medicine today. Since human urine is one of the most important fluids providing useful information about the body condition, appropriate pre-analytical techniques become critical towards its use within clinical and profiling applications. We discuss the top 6 strategies in sample handling and purification techniques that will lend itself towards the development of a standardized protocol and ultimately, a clean sample fit for investigation.

65 min (Q&A included)

Featured Speaker:

Iva Laska
Senior Life Science Product Specialist
×

Exosomes

Everything You Need to Know About Exosomes | From Purification to Disease Monitoring

An accumulation of evidence has shown that exosomes and other extracellular vesicles (EVs) complete cell-to-cell communication by transmitting information to different cells throughout the human body. However, the function and/or physiology of cells can actually be altered upon the transmission of the exosomal contents to a distant or neighbouring cell. Recent research has identified the presence of specific microRNA (miRNA) signatures within exosomes that are related to specific diseases and can be used as biomarkers. Exosomal miRNA profiles have been found to vary significantly depending on the purification or isolation methods used. Therefore, in order to create a reliable RNA profile that could be used as a biomarker, exosome purification and isolation techniques must be taken into consideration since exosomes mainly contain low concentrations of miRNA

82 min (Q&A included)

Featured Speaker:

Dr. Abdalla, MSc, PhD
Senior Research Scientist
Moderator: Alexandra White
Life Sciences Product Specialist
Register to download package Download Package
×

Plasma/Serum Cell-Free Nucleic Acids

Understanding the Basics and Applications of Plasma/Serum cf-DNA and cf-RNA

Cell-free DNA (cf-DNA) and cell-free RNA (cf-RNA) are considered important biomarkers in plasma and serum for the detection of several diseases and conditions. These cf-DNA and cf- RNA are generally released in the bloodstream as the cells undergo apoptosis or necrosis. The cf-DNA and cf-RNA levels alter as per the underlying physiological processes, which might be driven by a disease or a condition. This is the basis of the non-invasive diagnosis and disease monitoring as well as disease prevention. The accurate detection of the cf-DNA/cf-RNA content in plasma/serum is influenced by the procedures implemented in the purification of cf-DNA/cf- RNA. In this webinar, we will discuss the different types of collection devices available to separate and preserve plasma/serum from blood. We will also discuss how different chemistries may affect cf-DNA/cf-RNA profiles. The webinar will also focus on cf-DNA/cf-RNA analysis methodologies and how these molecules can be exploited to generate data from instruments as simple as Qubit to as sophisticated as Next Generation Sequencing.

45 min

Featured Speaker:

Alex Chauhan, M.Sc, Ph.D.
Research Scientist
Moderator: Alexandra White
Life Sciences Product Specialist
Register to download package Download Package
×

Unlocking the Importance of Urine Biomarkers

From Discovery to Diagnosis

The search for minimally invasive methods for the early detection of diseases is on the rise. In particular, the search for biomarkers among different diseases is showing promise as they have been successfully used within clinical settings for the early detection and monitoring of some cancers. While blood and tissue biopsy samples are commonly used within cancer research for biomarker discovery, urine is gaining considerable interest as an alternative sample type for that purpose. Circulating nucleic acids from both normal and cancer cells have been found in urine, which makes it an excellent sample source for the discovery of cancer-specific biomarkers. Recent evidence has exhibited a plethora of information that can be obtained from urine for the early detection of different cancer types, regardless of their location. Because of the nature and the origin of circulating nucleic acid, different cell-free DNA and cell-free RNA signatures have been identified in urine. Such differences are highly attributed to different factors, including the means of sample collection and the purification method used. In this webinar, we will be discussing what must be taken into consideration to unlock the importance of urine as a source for biomarker discovery.

29 min

Featured Speaker:

Michelle Stopher
NGS Key Account Manager
Moderator: Nikola Breberina
Life Sciences Product Specialist
Register to download package Q&A
Download Package
×

A Multi-Omics Look Into the Stool Microbiome

Stool Microbiome

The gastrointestinal (GI) tract is an integral system to humans and animals, but it does more beyond breaking food down, absorption, and waste excretion. The GI tract is inhabited with microbes with significant relationships to the host. The gut microbiome plays an integral role in pathologies, immunity, nutrition, metabolism, and has been connected with brain function. Another member of this region is the gut virome - consisting of bacteriophages, host viruses, and transient viruses - which plays a role that is not yet well defined. Host DNA is also shed in the GI tract and can be used as biomarkers for some host diseases. Invasive methods can provide an accurate description of the gut environment; however, these methods are not sustainable. Luckily, a snapshot of the gut activity can be obtained via a non-invasive sample type. Feces collected from the host is widely accepted and studied as a proxy for the gut. In this webinar, we will discuss different fecal collection and storage methods and delve into the information available from feces. The webinar will also explore the wide range of applications for this sample.

41 min

Featured Speaker:

Jason Byron Perez, M.Sc.
Senior Product Specialist
Moderator: Lea Milkin
Life Sciences Product Specialist
×

Liquid Biopsy: Paving the Path for NGS-Based Biomarker Discovery

Biomarker Discovery

Liquid biopsy samples are increasingly becoming one of the most valuable, minimally-invasive sources of information as the basis of diagnosis and disease monitoring as well as disease prevention. Biospecimens such as plasma, serum and urine contain various biomarkers that provide key insights into changes within the genome, epigenome, transcriptome and proteome of a patient. Next Generation Sequencing (NGS) is an extraordinary tool enabling researchers to dive deeper into the contents of liquid biopsy samples to advance discoveries in the fields of cancer research and complex disease genomics. In this webinar, we will discuss the various Next Generation Sequencing applications that can be explored which allow researchers to analyze the circulating analytes contained within liquid biopsy samples. We will focus a spotlight on Small (micro) RNA-Sequencing from cell-free RNA and RNA derived from exosomes, as an application for biomarker discovery and understanding cell to cell communication. We will also discuss the emerging field of transcriptome sequencing from cell-free RNA in liquid biopsy samples, the challenges of library preparation, and the immense potential of profiling circulating transcripts.

31 min

Featured Speaker:

Dr. Mohamed El-Mogy, M.Sc. Ph.D
Director of R&D Services
Michelle Stopher
Key Account Manager
×

Recent Advancements in Plant Pathogen Detection - Effective Diagnosis of Plant Diseases

Effective Diagnosis of Plant Diseases

Plant diseases and infections are a major factor in global crop failure, causing billions of dollars in economic loss each year and a significant impact on food security. Effective detection of plant pathogens is crucial to monitor crop and ecosystem health, and to determine best practices for remediation strategies.
Molecular diagnostic methods utilizing genetic material from the plant and pathogen provide a powerful tool for identifying diseases. It allows for fast and accurate detection of pathogens, often before visual cues of infection can be identified. In this webinar, we will focus on nucleic acid (DNA and RNA)-based detection methods for plant pathogens, including key considerations in the testing workflow and how to overcome common laboratory challenges.

32 min

Featured Speaker:

Regan Bak
Senior Product Specialist